Cargando…
Blood pressure measurement at two years in offspring of women randomized to a trial of metformin for GDM: follow up data from the MiG trial
BACKGROUND: Offspring born following maternal gestational diabetes are at risk of excessive childhood weight gain and Type 2 diabetes in childhood, which in turn is associated with an increased rate of hypertension. We aimed to determine the systolic and diastolic blood pressure at two years of age...
Autores principales: | Battin, Malcolm R, Obolonkin, Victor, Rush, Elaine, Hague, William, Coat, Suzette, Rowan, Janet |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4429316/ https://www.ncbi.nlm.nih.gov/pubmed/25943394 http://dx.doi.org/10.1186/s12887-015-0372-1 |
Ejemplares similares
-
Metformin in Gestational Diabetes: The Offspring Follow-Up (MiG TOFU): Body composition at 2 years of age
por: Rowan, Janet A., et al.
Publicado: (2011) -
Metformin in gestational diabetes: the offspring follow-up (MiG TOFU): body composition and metabolic outcomes at 7–9 years of age
por: Rowan, Janet A, et al.
Publicado: (2018) -
Response to Comments on: Rowan et al. Metformin in Gestational Diabetes: The Offspring Follow-Up (MiG TOFU): Body Composition at 2 Years of Age. Diabetes Care 2011;34:2279–2284
por: Rowan, Janet A., et al.
Publicado: (2012) -
Maternal and Neonatal Circulating Markers of Metabolic and Cardiovascular Risk in the Metformin in Gestational Diabetes (MiG) Trial: Responses to maternal metformin versus insulin treatment
por: Barrett, Helen L., et al.
Publicado: (2013) -
Determinants of Maternal Triglycerides in Women With Gestational Diabetes Mellitus in the Metformin in Gestational Diabetes (MiG) Study
por: Barrett, Helen L., et al.
Publicado: (2013)